SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

A Meaningful Step Forward in Stent Technology

The SYNERGY BP Stent is the first and only FDA-approved drug-eluting stent with abluminal bioabsorbable polymer coating available in the U.S. It was designed to address the challenges associated with permanent polymer stents such as inflammation, neoatherosclerosis and late stent thrombosis.

The SYNERGY BP Stent provides synchronous drug elution and polymer absorption; the polymer is absorbed shortly after the drug elution is complete at 3-months, providing rapid healing and freedom from long-term polymer exposure. Learn more

Watch Video: Outstanding Results from the Swedish SCAAR Registry

The SYNERGY BP Stent demonstrated the numerically lowest stent thrombosis rates compared to other DES, despite being used in patients with more complex disease.1 The SCAAR registry is a national, 20-hospital registry of data relating to stent performance in Sweden.
Outstanding Results from the Swedish SCAAR Registry
 
Early Healing

Early Healing

Advanced design for optimal healing

Button
Clinical Outcomes

Clinical Outcomes

Outstanding evidence across trials

Button
Efficiency

Efficiency

How design impacts economic value

Button
Top